Antiretroviral-treated HIV-infected women have similar long-term kidney function trajectories as HIV-uninfected women

Michelle M. Estrella, Alison G. Abraham, Yuezhou Jing, Rulan S. Parekh, Phyllis C. Tien, Dan Merenstein, Celeste Leigh Pearce, Kathryn Anastos, Mardge H. Cohen, Jack A. Dehovitz, Stephen J. Gange

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Natural history studies suggest increased risk for kidney function decline with HIV infection, but few studies have made comparisons with HIV-uninfected women. We examined whether HIV infection treated with highly active antiretroviral therapy (HAART) remains associated with faster kidney function decline in the Women's Interagency HIV Study. HIV-infected women initiating HAART with (n=105) or without (n=373) tenofovir (TDF) were matched to HIV-uninfected women on calendar and length of follow-up, age, systolic blood pressure, hepatitis C antibody serostatus, and diabetes history. Linear mixed models were used to evaluate differences in annual estimated glomerular filtration rate (eGFR). Person-visits were 4,741 and 11,512 for the TDF-treated and non-TDF-treated analyses, respectively. Mean baseline eGFRs were higher among women initiated on TDF-containing HAART and lower among those on TDF-sparing HAART compared to their respective HIV-uninfected matches (p<0.05 for both). HIV-infected women had annual rates of eGFR changes similar to HIV-uninfected matches (p-interaction >0.05 for both). Adjusting for baseline eGFR, mean eGFRs at 1 and 3 years of follow-up among women initiated on TDF-containing HAART were lower than their uninfected matches (-4.98 and-4.26 ml/min/1.73 m2, respectively; p<0.05 for both). Mean eGFR of women initiated on TDF-sparing HAART was lower versus uninfected matches at 5 years (-2.19 ml/min/1.73 m2, p=0.03). HAART-treated HIV-infected women had lower mean eGFRs at follow-up but experienced rates of annual eGFR decline similar to HIV-uninfected women. Tenofovir use in HIV-infected women with normal kidney function did not accelerate long-term kidney function decline relative to HIV-uninfected women.

Original languageEnglish (US)
Pages (from-to)755-760
Number of pages6
JournalAIDS Research and Human Retroviruses
Volume29
Issue number5
DOIs
StatePublished - 2013
Externally publishedYes

Fingerprint

HIV
Highly Active Antiretroviral Therapy
Kidney
Tenofovir
Glomerular Filtration Rate
HIV Infections
Blood Pressure
Hepatitis C Antibodies
Natural History
Linear Models
History

ASJC Scopus subject areas

  • Immunology
  • Virology
  • Infectious Diseases

Cite this

Estrella, M. M., Abraham, A. G., Jing, Y., Parekh, R. S., Tien, P. C., Merenstein, D., ... Gange, S. J. (2013). Antiretroviral-treated HIV-infected women have similar long-term kidney function trajectories as HIV-uninfected women. AIDS Research and Human Retroviruses, 29(5), 755-760. https://doi.org/10.1089/aid.2012.0248

Antiretroviral-treated HIV-infected women have similar long-term kidney function trajectories as HIV-uninfected women. / Estrella, Michelle M.; Abraham, Alison G.; Jing, Yuezhou; Parekh, Rulan S.; Tien, Phyllis C.; Merenstein, Dan; Pearce, Celeste Leigh; Anastos, Kathryn; Cohen, Mardge H.; Dehovitz, Jack A.; Gange, Stephen J.

In: AIDS Research and Human Retroviruses, Vol. 29, No. 5, 2013, p. 755-760.

Research output: Contribution to journalArticle

Estrella, MM, Abraham, AG, Jing, Y, Parekh, RS, Tien, PC, Merenstein, D, Pearce, CL, Anastos, K, Cohen, MH, Dehovitz, JA & Gange, SJ 2013, 'Antiretroviral-treated HIV-infected women have similar long-term kidney function trajectories as HIV-uninfected women', AIDS Research and Human Retroviruses, vol. 29, no. 5, pp. 755-760. https://doi.org/10.1089/aid.2012.0248
Estrella, Michelle M. ; Abraham, Alison G. ; Jing, Yuezhou ; Parekh, Rulan S. ; Tien, Phyllis C. ; Merenstein, Dan ; Pearce, Celeste Leigh ; Anastos, Kathryn ; Cohen, Mardge H. ; Dehovitz, Jack A. ; Gange, Stephen J. / Antiretroviral-treated HIV-infected women have similar long-term kidney function trajectories as HIV-uninfected women. In: AIDS Research and Human Retroviruses. 2013 ; Vol. 29, No. 5. pp. 755-760.
@article{de3da34f81d54a13b49797a6695d63a7,
title = "Antiretroviral-treated HIV-infected women have similar long-term kidney function trajectories as HIV-uninfected women",
abstract = "Natural history studies suggest increased risk for kidney function decline with HIV infection, but few studies have made comparisons with HIV-uninfected women. We examined whether HIV infection treated with highly active antiretroviral therapy (HAART) remains associated with faster kidney function decline in the Women's Interagency HIV Study. HIV-infected women initiating HAART with (n=105) or without (n=373) tenofovir (TDF) were matched to HIV-uninfected women on calendar and length of follow-up, age, systolic blood pressure, hepatitis C antibody serostatus, and diabetes history. Linear mixed models were used to evaluate differences in annual estimated glomerular filtration rate (eGFR). Person-visits were 4,741 and 11,512 for the TDF-treated and non-TDF-treated analyses, respectively. Mean baseline eGFRs were higher among women initiated on TDF-containing HAART and lower among those on TDF-sparing HAART compared to their respective HIV-uninfected matches (p<0.05 for both). HIV-infected women had annual rates of eGFR changes similar to HIV-uninfected matches (p-interaction >0.05 for both). Adjusting for baseline eGFR, mean eGFRs at 1 and 3 years of follow-up among women initiated on TDF-containing HAART were lower than their uninfected matches (-4.98 and-4.26 ml/min/1.73 m2, respectively; p<0.05 for both). Mean eGFR of women initiated on TDF-sparing HAART was lower versus uninfected matches at 5 years (-2.19 ml/min/1.73 m2, p=0.03). HAART-treated HIV-infected women had lower mean eGFRs at follow-up but experienced rates of annual eGFR decline similar to HIV-uninfected women. Tenofovir use in HIV-infected women with normal kidney function did not accelerate long-term kidney function decline relative to HIV-uninfected women.",
author = "Estrella, {Michelle M.} and Abraham, {Alison G.} and Yuezhou Jing and Parekh, {Rulan S.} and Tien, {Phyllis C.} and Dan Merenstein and Pearce, {Celeste Leigh} and Kathryn Anastos and Cohen, {Mardge H.} and Dehovitz, {Jack A.} and Gange, {Stephen J.}",
year = "2013",
doi = "10.1089/aid.2012.0248",
language = "English (US)",
volume = "29",
pages = "755--760",
journal = "AIDS Research and Human Retroviruses",
issn = "0889-2229",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - Antiretroviral-treated HIV-infected women have similar long-term kidney function trajectories as HIV-uninfected women

AU - Estrella, Michelle M.

AU - Abraham, Alison G.

AU - Jing, Yuezhou

AU - Parekh, Rulan S.

AU - Tien, Phyllis C.

AU - Merenstein, Dan

AU - Pearce, Celeste Leigh

AU - Anastos, Kathryn

AU - Cohen, Mardge H.

AU - Dehovitz, Jack A.

AU - Gange, Stephen J.

PY - 2013

Y1 - 2013

N2 - Natural history studies suggest increased risk for kidney function decline with HIV infection, but few studies have made comparisons with HIV-uninfected women. We examined whether HIV infection treated with highly active antiretroviral therapy (HAART) remains associated with faster kidney function decline in the Women's Interagency HIV Study. HIV-infected women initiating HAART with (n=105) or without (n=373) tenofovir (TDF) were matched to HIV-uninfected women on calendar and length of follow-up, age, systolic blood pressure, hepatitis C antibody serostatus, and diabetes history. Linear mixed models were used to evaluate differences in annual estimated glomerular filtration rate (eGFR). Person-visits were 4,741 and 11,512 for the TDF-treated and non-TDF-treated analyses, respectively. Mean baseline eGFRs were higher among women initiated on TDF-containing HAART and lower among those on TDF-sparing HAART compared to their respective HIV-uninfected matches (p<0.05 for both). HIV-infected women had annual rates of eGFR changes similar to HIV-uninfected matches (p-interaction >0.05 for both). Adjusting for baseline eGFR, mean eGFRs at 1 and 3 years of follow-up among women initiated on TDF-containing HAART were lower than their uninfected matches (-4.98 and-4.26 ml/min/1.73 m2, respectively; p<0.05 for both). Mean eGFR of women initiated on TDF-sparing HAART was lower versus uninfected matches at 5 years (-2.19 ml/min/1.73 m2, p=0.03). HAART-treated HIV-infected women had lower mean eGFRs at follow-up but experienced rates of annual eGFR decline similar to HIV-uninfected women. Tenofovir use in HIV-infected women with normal kidney function did not accelerate long-term kidney function decline relative to HIV-uninfected women.

AB - Natural history studies suggest increased risk for kidney function decline with HIV infection, but few studies have made comparisons with HIV-uninfected women. We examined whether HIV infection treated with highly active antiretroviral therapy (HAART) remains associated with faster kidney function decline in the Women's Interagency HIV Study. HIV-infected women initiating HAART with (n=105) or without (n=373) tenofovir (TDF) were matched to HIV-uninfected women on calendar and length of follow-up, age, systolic blood pressure, hepatitis C antibody serostatus, and diabetes history. Linear mixed models were used to evaluate differences in annual estimated glomerular filtration rate (eGFR). Person-visits were 4,741 and 11,512 for the TDF-treated and non-TDF-treated analyses, respectively. Mean baseline eGFRs were higher among women initiated on TDF-containing HAART and lower among those on TDF-sparing HAART compared to their respective HIV-uninfected matches (p<0.05 for both). HIV-infected women had annual rates of eGFR changes similar to HIV-uninfected matches (p-interaction >0.05 for both). Adjusting for baseline eGFR, mean eGFRs at 1 and 3 years of follow-up among women initiated on TDF-containing HAART were lower than their uninfected matches (-4.98 and-4.26 ml/min/1.73 m2, respectively; p<0.05 for both). Mean eGFR of women initiated on TDF-sparing HAART was lower versus uninfected matches at 5 years (-2.19 ml/min/1.73 m2, p=0.03). HAART-treated HIV-infected women had lower mean eGFRs at follow-up but experienced rates of annual eGFR decline similar to HIV-uninfected women. Tenofovir use in HIV-infected women with normal kidney function did not accelerate long-term kidney function decline relative to HIV-uninfected women.

UR - http://www.scopus.com/inward/record.url?scp=84876948626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876948626&partnerID=8YFLogxK

U2 - 10.1089/aid.2012.0248

DO - 10.1089/aid.2012.0248

M3 - Article

C2 - 23273313

AN - SCOPUS:84876948626

VL - 29

SP - 755

EP - 760

JO - AIDS Research and Human Retroviruses

JF - AIDS Research and Human Retroviruses

SN - 0889-2229

IS - 5

ER -